AAAAAA

   
Results: 1-11 |
Results: 11
IMPACT OF HIGH-DOSE SALVAGE THERAPY (BEAM) ON OVERALL SURVIVAL IN YOUNGER PATIENTS WITH ADVANCED LARGE-CELL LYMPHOMAS ENTERED INTO BNLI TRIALS
Authors: LINCH DC HUDSON BV ANDERSON L HUDSON GV
Citation: Dc. Linch et al., IMPACT OF HIGH-DOSE SALVAGE THERAPY (BEAM) ON OVERALL SURVIVAL IN YOUNGER PATIENTS WITH ADVANCED LARGE-CELL LYMPHOMAS ENTERED INTO BNLI TRIALS, Annals of oncology, 8, 1997, pp. 63-65
THE CLINICAL OUTCOME OF 65 CASES OF MANTLE CELL LYMPHOMA INITIALLY TREATED WITH NON-INTENSIVE THERAPY BY THE BRITISH NATIONAL LYMPHOMA INVESTIGATION GROUP
Authors: VANDENBERGHE E DEWOLFPEETERS C HUDSON GV HUDSON BV PITTALUGA S ANDERSON L LINCH DC
Citation: E. Vandenberghe et al., THE CLINICAL OUTCOME OF 65 CASES OF MANTLE CELL LYMPHOMA INITIALLY TREATED WITH NON-INTENSIVE THERAPY BY THE BRITISH NATIONAL LYMPHOMA INVESTIGATION GROUP, British Journal of Haematology, 99(4), 1997, pp. 842-847
OUTCOME OF MANTLE CELL LYMPHOMAS - A STUDY FROM THE BRITISH NATIONAL LYMPHOMA INVESTIGATION GROUP (BNLI)
Authors: VANDENBERGHE E DEWOLFPEETERS C HUDSON GV HUDSON BV ANDERSON L LINCH DC
Citation: E. Vandenberghe et al., OUTCOME OF MANTLE CELL LYMPHOMAS - A STUDY FROM THE BRITISH NATIONAL LYMPHOMA INVESTIGATION GROUP (BNLI), British Journal of Haematology, 93, 1996, pp. 282-282
A RANDOMIZED COMPARISON OF A 3RD-GENERATION REGIMEN (PACEBOM) WITH A STANDARD REGIMEN (CHOP) IN PATIENTS WITH HISTOLOGICALLY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A BRITISH NATIONAL LYMPHOMA INVESTIGATION REPORT
Authors: LINCH DC HUDSON BV HANCOCK BW HOSKIN PJ CUNNINGHAM DC NEWLAND AC MILLIGAN DW STEVENSON PA WOOD JK MACLENNAN KA ANDERSON L GREGORY WM HUDSON GV
Citation: Dc. Linch et al., A RANDOMIZED COMPARISON OF A 3RD-GENERATION REGIMEN (PACEBOM) WITH A STANDARD REGIMEN (CHOP) IN PATIENTS WITH HISTOLOGICALLY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A BRITISH NATIONAL LYMPHOMA INVESTIGATION REPORT, British Journal of Cancer, 74(2), 1996, pp. 318-322
PROGNOSTIC-SIGNIFICANCE OF BCL-2 EXPRESSION AND BCL-2 MAJOR BREAKPOINT REGION REARRANGEMENT IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA - ABRITISH NATIONAL LYMPHOMA INVESTIGATION STUDY
Authors: HILL ME MACLENNAN KA CUNNINGHAM DC HUDSON BV BURKE M CLARKE P DISTEFANO F ANDERSON L HUDSON GV MASON D SELBY P LINCH DC
Citation: Me. Hill et al., PROGNOSTIC-SIGNIFICANCE OF BCL-2 EXPRESSION AND BCL-2 MAJOR BREAKPOINT REGION REARRANGEMENT IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA - ABRITISH NATIONAL LYMPHOMA INVESTIGATION STUDY, Blood, 88(3), 1996, pp. 1046-1051
LATE MORTALITY IN YOUNG BNLI PATIENTS CURED OF HODGKINS-DISEASE
Authors: HUDSON BV HUDSON GV LINCH DC ANDERSON L
Citation: Bv. Hudson et al., LATE MORTALITY IN YOUNG BNLI PATIENTS CURED OF HODGKINS-DISEASE, Annals of oncology, 5, 1994, pp. 190000065-190000066
HYBRID LOPP EVA IS NOT BETTER THAN LOPP ALTERNATING WITH EVAP - A PREMATURELY TERMINATED BRITISH NATIONAL LYMPHOMA INVESTIGATION RANDOMIZEDTRIAL
Authors: HANCOCK BW HUDSON GV HUDSON BV LINCH DC ANDERSON L MACLENNAN KA
Citation: Bw. Hancock et al., HYBRID LOPP EVA IS NOT BETTER THAN LOPP ALTERNATING WITH EVAP - A PREMATURELY TERMINATED BRITISH NATIONAL LYMPHOMA INVESTIGATION RANDOMIZEDTRIAL, Annals of oncology, 5, 1994, pp. 190000117-190000120
EFFICACY AND TOXICITY OF VINBLASTINE, BLEOMYCIN, AND METHOTREXATE WITH INVOLVED-FIELD RADIOTHERAPY IN CLINICAL STAGE IA AND IIA HODGKINS-DISEASE - A BRITISH NATIONAL LYMPHOMA INVESTIGATION PILOT-STUDY
Authors: BOTES NP WILLIAMS MV BESSELL EM HUDSON GV HUDSON BV
Citation: Np. Botes et al., EFFICACY AND TOXICITY OF VINBLASTINE, BLEOMYCIN, AND METHOTREXATE WITH INVOLVED-FIELD RADIOTHERAPY IN CLINICAL STAGE IA AND IIA HODGKINS-DISEASE - A BRITISH NATIONAL LYMPHOMA INVESTIGATION PILOT-STUDY, Journal of clinical oncology, 12(2), 1994, pp. 288-296
CLINICAL STAGE-1 NON-HODGKINS-LYMPHOMA - LONG-TERM FOLLOW-UP OF PATIENTS TREATED BY THE BRITISH NATIONAL LYMPHOMA INVESTIGATION WITH RADIOTHERAPY ALONE AS INITIAL THERAPY
Authors: HUDSON BV HUDSON GV MACLENNAN KA ANDERSON L LINCH DC
Citation: Bv. Hudson et al., CLINICAL STAGE-1 NON-HODGKINS-LYMPHOMA - LONG-TERM FOLLOW-UP OF PATIENTS TREATED BY THE BRITISH NATIONAL LYMPHOMA INVESTIGATION WITH RADIOTHERAPY ALONE AS INITIAL THERAPY, British Journal of Cancer, 69(6), 1994, pp. 1088-1093
NON-HODGKINS-LYMPHOMA OF THE TESTIS
Authors: CRELLIN AM HUDSON BV BENNETT MH HARLAND S HUDSON GV
Citation: Am. Crellin et al., NON-HODGKINS-LYMPHOMA OF THE TESTIS, Radiotherapy and oncology, 27(2), 1993, pp. 99-106
RISK OF 2ND PRIMARY-CANCER AFTER HODGKINS-DISEASE IN PATIENTS IN THE BRITISH-NATIONAL-LYMPHOMA-INVESTIGATION - RELATIONSHIPS TO HOST FACTORS, HISTOLOGY AND STAGE OF HODGKINS-DISEASE, AND SPLENECTOMY
Authors: SWERDLOW AJ DOUGLAS AJ HUDSON GV HUDSON BV MACLENNAN KA
Citation: Aj. Swerdlow et al., RISK OF 2ND PRIMARY-CANCER AFTER HODGKINS-DISEASE IN PATIENTS IN THE BRITISH-NATIONAL-LYMPHOMA-INVESTIGATION - RELATIONSHIPS TO HOST FACTORS, HISTOLOGY AND STAGE OF HODGKINS-DISEASE, AND SPLENECTOMY, British Journal of Cancer, 68(5), 1993, pp. 1006-1011
Risultati: 1-11 |